Antibody Immunological Imprinting on COVID-19 Patients

0 views • Oct 30, 2021
0
Save
Cite
Share

Author(s)

Author Name

Teresa Aydillo

Alexander Rombauts

Published 1 Project

Infectious Diseases

Sadaf Aslam

Published 2 Projects

Infectious Diseases

Gabriela Abelenda-Alonso

Published 1 Project

Infectious Diseases

Alba Escalera

Published 1 Project

Infectious Diseases

Kaijun Jiang

Uploader

Florian Krammer

Uploader

Florian Krammer

Add New Author

While the current pandemic remains a thread to human health, the polyclonal nature of the antibody response against SARS-CoV-2 is not fully understood. Other than SARS-CoV-2, humans are susceptible to six different coronaviruses, and previous exposure to antigenically related and divergent seasonal coronaviruses is frequent. We longitudinally profiled the early humoral immune response against SARS-CoV-2 on hospitalized COVID-19 patients, and quantify levels of pre-existing immunity to OC43, HKU1 and 223E seasonal coronaviruses. A strong back-boosting effect to conserved, but not variable regions of OC43 and HKU1 betacoronaviruses spike protein was observed. All patients developed antibodies against SARS-CoV-2 spike and nucleoprotein, with peak induction at day 7 post hospitalization. However a negative correlation was found between antibody memory boost to human coronaviruses and induction of IgG and IgM against SARS-CoV-2 spike. Our findings provide evidence of immunological imprinting that determine the antibody profile to COVID-19 patients in an original antigenic sin fashion.

Infectious Diseases
Infectious Diseases 62 Projects